Publicações

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

AuthID
P-00Z-DQE

Author(s)

Khan, MS

Anker, SD

Filippatos, G

Ferreira, JP

Pocock, SJ

Januzzi, JL

Chopra, VK

Piña, IL

Böhm, M

Ponikowski, P

Verma, S

Brueckmann, M

Vedin, O

Peil, B

Zannad, F

Packer, M

Butler, J

Tipo de Documento

Article

Year published

2023

Publicado

in JOURNAL OF CARDIAC FAILURE, ISSN: 1071-9164

Volume: 29, Número: 10, Páginas: 1345-1354 (10)

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.cardfail.2023.06.024

Pubmed: 37558088

Wos: WOS:001103175200001

Source Identifiers

ISSN: 1071-9164

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

Links Úteis

Ajuda